Shanghai Chenggeng Biotechnology Co.
Latest round
- Series A
Last raised
- Dec 2025
Total raised
- $28M
Investors
- 2
About Shanghai Chenggeng Biotechnology Co.
, is a provider of comprehensive precision microbiome transplantation solutions, primarily engaged in the development of the Precision Microbiome Transplantation Treatment Platform (PMTT)., is a provider of comprehensive precision microbiome transplantation solutions, primarily engaged in the development of the Precision Microbiome Transplantation Treatment Platform (PMTT)., Ltd. It specializes in human microbiome transplantation, with business areas spanning microbiome health, microbiome diagnostics, microbiome therapy, microbiome drugs, and microbiome medical big data mining. The company generates revenue by providing comprehensive solutions for precision microbiome transplantation.
Who invested in Shanghai Chenggeng Biotechnology Co.
2 investors across 2 rounds
See all investors in Shanghai Chenggeng Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Shanghai Chenggeng Biotechnology Co.
Who invested in Shanghai Chenggeng Biotechnology Co.?
Shanghai Chenggeng Biotechnology Co. has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shanghai Chenggeng Biotechnology Co. raised?
Shanghai Chenggeng Biotechnology Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Shanghai Chenggeng Biotechnology Co. last raise money?
Shanghai Chenggeng Biotechnology Co.'s most recent round on record is a Series A, in Dec 2025.
What does Shanghai Chenggeng Biotechnology Co. do?
, is a provider of comprehensive precision microbiome transplantation solutions, primarily engaged in the development of the Precision Microbiome Transplantation Treatment Platform (PMTT).
Where is Shanghai Chenggeng Biotechnology Co. headquartered?
Shanghai Chenggeng Biotechnology Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Shanghai Chenggeng Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Shanghai Chenggeng Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Shanghai Chenggeng Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.